RTOG 94-02

PHASE III INTERGROUP RANDOMIZED COMPARISON OF RADIATION ALONE vs PRE-RADIATION CHEMOTHERAPY FOR PURE AND MIXED ANAPLASTIC OLIGODENDROGLIOMA

RTOG 94-08

A PHASE III TRIAL OF THE STUDY OF ENDOCRINE THERAPY USED AS A CYTOREDUCTIVE AND CYTOSTATIC AGENT PRIOR TO RADIATION THERAPY IN GOOD PROGNOSIS LOCALLY CONFINED ADENOCARCINOMA OF THE PROSTATE

RTOG 96-01

A PHASE III TRIAL OF RADIATION THERAPY WITH OR WITHOUT CASODEX IN PATIENTS WITH PSA ELEVATION FOLLOWING RADICAL PROSTATECTOMY FOR pT3N0 CARCINOMA OF THE PROSTATE

RTOG 98-01

A PHASE III RANDOMIZED STUDY OF AMIFOSTINE MUCOSAL PROTECTION FOR PATIENTS WITH FAVORABLE PERFORMANCE INOPERABLE STAGE II-IIIA/B NON-SMALL CELL LUNG CANCER (NSCLC) RECEIVING SEQUENTIAL INDUCTION AND CONCURRENT HYPERFRACTIONATED RADIOTHERAPY WITH PACLITAXEL AND CARBOPLATIN

RTOG 98-02

A PHASE II STUDY OF OBSERVATION IN FAVORABLE LOW-GRADE GLIOMA AND PHASE III STUDY OF RADIATION WITH OR WITHOUT PCV CHEMOTHERAPY IN UNFAVORABLE LOW-GRADE GLIOMA

RTOG 97-14

RANDOMIZED TRIAL OF PALLIATIVE RADIATION THERAPY FOR OSSEOUS METASTASES: A STUDY OF PALLIATION OF SYMPTOMS AND QUALITY OF LIFE

RTOG 99-02

A PHASE III PROTOCOL OF ANDROGEN SUPPRESSION (AS) AND RADIATION THERAPY (RT) VS AS AND RT FOLLOWED BY CHEMOTHERAPY WITH PACLITAXEL, ESTRAMUSTINE, AND ETOPOSIDE (TEE) FOR LOCALIZED, HIGH-RISK, PROSTATE CANCER

RTOG 99-03

(PENDING APPROVAL)

A RANDOMIZED PHASE III TRIAL TO ASSESS THE EFFECT OF ERYTHROPOIETIN ON LOCAL-REGIONAL CONTROL IN ANEMIC PATIENTS TREATED WITH RADIOTHERAPY FOR CARCINOMA OF THE HEAD AND NECK

RTOG 99-10

A PHASE III TRIAL TO EVALUATE THE DURATION OF NEOADJUVANT TOTAL ANDROGEN SUPPRESSION (TAS) AND RADIATION THERAPY (RT) IN INTERMEDIATE-RISK PROSTATE CANCER